Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 76.10M | 66.86M | 59.37M | 50.27M | 43.13M | 43.52M |
Gross Profit | 33.12M | 27.48M | 25.69M | 19.06M | 16.97M | 19.36M |
EBITDA | -16.91M | -3.98M | ― | -5.20M | 5.90M | -66.50K |
Net Income | -20.48M | -7.23M | -9.20M | -13.29M | 393.78K | -8.89M |
Balance Sheet | ||||||
Total Assets | 46.96M | 44.12M | 48.45M | 45.76M | 52.94M | 63.79M |
Cash, Cash Equivalents and Short-Term Investments | 7.05M | 3.91M | 5.34M | 9.91M | 15.44M | 20.38M |
Total Debt | 22.56M | 23.12M | 26.75M | 21.84M | 9.26M | 15.17M |
Total Liabilities | 43.11M | 39.15M | 40.11M | 31.12M | 29.39M | 31.84M |
Stockholders Equity | 3.62M | 4.71M | 7.69M | 13.94M | 22.59M | 30.87M |
Cash Flow | ||||||
Free Cash Flow | -765.86K | -5.25M | -4.99M | -17.94M | -11.12M | -5.66M |
Operating Cash Flow | 1.54M | -3.95M | -2.23M | -16.09M | -10.05M | -4.09M |
Investing Cash Flow | -2.33M | -1.26M | -5.63M | 6.61M | 840.90K | 764.55K |
Financing Cash Flow | 1.65M | 4.40M | 2.04M | 5.02M | 4.45M | 24.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
56 Neutral | 2.77M | -1.98 | 0.00% | ― | -5.08% | 93.27% | |
52 Neutral | $3.56M | <0.01 | -1102.76% | ― | 16.50% | ― | |
46 Neutral | 6.46M | -0.79 | -163.40% | ― | 30.52% | 56.70% | |
39 Underperform | 8.86M | -0.13 | 334.28% | ― | -33.86% | 74.09% | |
34 Underperform | 25.27M | >-0.01 | 0.00% | ― | 0.00% | 0.00% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
Cemtrex, Inc. faced a compliance issue with Nasdaq’s minimum stockholder’s equity requirement, which mandates a minimum equity of $2.5 million. On February 21, 2025, the company was notified of its non-compliance due to its equity falling below this threshold. However, by June 4, 2025, Cemtrex had successfully regained compliance, reporting a stockholder’s equity of $6,403,022, thus resolving the issue.